Qing Yi

Mianyang Normal University — China

Medicine · Health Sciences

62h-index13.7kcitations311works14.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Myeloma Research and Treatments(99), Immunotherapy and Immune Responses(89), T-cell and B-cell Immunology(57), Immune Cell Function and Interaction(49), CAR-T cell therapy research(33)

Publications311 total

Analysis of Intestinal Microbiota Differences and Functional Prediction Between Sichuan-Tibetan Black Pigs and Landrace Pigs
Microorganisms·2026Open Access
Novel DKK1-A2 CAR-T cell therpy for hematologic malignancies
Blood·2025Open Access
Comparison of Gut Microbial Structure and Function Changes in Sichuan–Tibetan Black Pigs at Different Growth Stages Based on Metagenomic Analysis
Current Issues in Molecular Biology·2025Open Access
Equal survival for Black Americans with multiple myeloma when appropriately matched to White Americans
Blood Cancer Journal·2025Open Access
Case Report: A case of first-line treatment for rare ROS1 fusion mutation lung adenocarcinoma with entrectinib
Frontiers in Oncology·2025Open Access
Adoptively transferred tumor-specific IL-9-producing cytotoxic CD8+ T cells activate host CD4+ T cells to control tumors with antigen loss
Nature Cancer·2025· 3 cited
Marvelon suppresses MC38 tumor growth and promotes anti-tumor immunity
Molecular Immunology·2025
Table tennis coaching system based on a multimodal large language model with a table tennis knowledge base
PLoS ONE·2025· 7 citedOpen Access
Targeting caseinolytic mitochondrial matrix peptidase, a novel contributor to the pathobiology of high-risk multiple myeloma
Blood·2025· 5 cited
MultiSpace Deep Fascial Infection in the Head and Neck Patient Complicated with Guillain-Barre Syndrome: Case Report with a Literature Review
Ear Nose & Throat Journal·2025Open Access
Depletion of myeloid-derived suppressor cells sensitizes murine multiple myeloma to PD-1 checkpoint inhibitors
Journal for ImmunoTherapy of Cancer·2025· 7 citedOpen Access
Adsl, As a Hub for Amino Acid Metabolism and Glucose Metabolism, Promotes the Development of Multiple Myeloma
Blood·2024Open Access
P-068 Developing Novel DKK1-A2 CAR-T Cell Therapy for Myeloma and Other Hematologic Malignancies
Clinical Lymphoma Myeloma & Leukemia·2024
OA-37 Targeting LILRB1 to Sensitize Human Myeloma to Ferroptosis by Disrupting Cholesterol Homeostasis
Clinical Lymphoma Myeloma & Leukemia·2024
Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis
Nature Communications·2024· 25 citedOpen Access
Th9 Cells Represent a Unique Subset of CD4+ T Cells Endowed with the Ability to Eradicate Advanced Tumors
Cancer Cell·2024· 2 citedOpen Access
Abstract 3606: Tumor-specific CD8+ Tc9 cells activate host CD4+ T cells to control antigen-lost tumors
Cancer Research·2024
Abstract 364: Targeting LILRB1 to sensitize human myeloma to ferroptosis through disrupting cholesterol homeostasis
Cancer Research·2024
Abstract 2821: Development of therapeutic monoclonal antibodies against DKK1 peptide-HLA-A2 complex to treat human cancers
Cancer Research·2024
A guideline on the molecular ecosystem regulating ferroptosis
Nature Cell Biology·2024· 215 citedOpen Access
page 1 of 16Next →

Frequent Co-authors

Jianfei Qian(23), Jing Yang(14), Larry W. Kwak(13), Yong Lu(8), Yuhuan Zheng(8), Xingzhe Ma(7), Enguang Bi(7), Siqing Wang(7), Michael Wang(7), Bart Barlogie(7), Pei Lin(7), Maojie Yang(6), Sungyoul Hong(6), Zhiqiang Liu(5), Zhen Cai(5), Lintao Liu(4), Qiang Wang(4), Yong Lu(4), Bo Wan(4), Long Yu(4)